Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate...

Corporation (IRC) developed this immunotherapy and licensed the technology to Dendreon, which obtained FDA clearance. The current approaches for DC-based vaccination...

Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer...

countries. CJ was recently reported to be in talks with the US Corporation Dendreon which is in trials with a cancer vaccine called Provenge. [citation needed]...

company had sold its skincare brands to L'Oréal for $1.3 billion and its Dendreon biotech unit to Sanpower for $819.9 million. In June, the company sold...

by 44.2 months, versus 30.6 months for the control. On April 14, 2009, Dendreon Corporation announced that their Phase III clinical trial of sipuleucel-T...

Airlines (#459), and Expedia (#500). Alder Biopharmaceuticals (Bothell) Dendreon – immunotherapeutics (defunct) Juno Therapeutics NanoString Technologies...

throughout the world. He is also an educational speaker on behalf of Amgen, Dendreon and Sanofi-Aventis. The New York Times Publishers Weekly ABC News ABC News...

entrepreneur who co-founded Immunex Corp. and Icos Corporation, and led Dendreon Corp. to the development of the first FDA-approved cancer vaccination therapy...

not able to produce enough efficient antibodies. Provenge, developed by Dendreon, was the first therapeutic vaccine approved by the FDA in 2010. This therapeutic...

per ep' Aigupton epistrateuontai, oudeni de allôi apelaunontai apo tôn dendreôn ê tês sturakos tôi kapnôi. Pastrorova et al. (1997) Hébert et al. (2004)...

no vaccines able to prevent cancer in general. On April 14, 2009, The Dendreon Corporation announced that their Phase III clinical trial of Provenge,...

all indication of rNAPc2 and other rNAPc molecules owned by Dendreon Corporation. Dendreon was paid an upfront fee of $4.0 million with an additional $23...

1186/1471-2490-6-6. PMC 1420318. PMID 16519806. "Dendreon: Targeting Cancer, Transforming Lives". Dendreon Corporation. 2005-09-21. Archived from the original...

a therapeutic cancer vaccine (TCV) in development (clinical trial) by Dendreon (DNDN). It uses the "immunotherapy platform approach" first successfully...

companies Samuel Strober, 1966, co-founder of a biotechnology company, Dendreon, that developed the first FDA approved cancer vaccination Daniel Voytas...

for antigen-presenting dendritic cells, that startup changed its name to Dendreon. Its major investor was Paul Allen (Vulcan Ventures owned 22% of the company...

former chief of the Division of Immunology and Rheumatology, co-founder of Dendreon Konstantina M. Stankovic – Bertarelli Foundation Professor and Chair of...

17, 2003 "Ex-CEO of East Brunswick's Savient Pharmaceuticals headed to Dendreon". nj. 2012-02-01. Retrieved 2020-05-12. "Savient Pharmaceuticals files...

School of Medicine (1979–1997); a co-founder of a biotechnology company, Dendreon, that developed the first FDA approved cancer vaccination; President of...

Cambridge Biosciences, The Virus Research Institute, ProScript, LeukoSite, Dendreon, Diversa, X-VAX, and Demetrix. He was a founder chairman and CEO of Human...

time of his death, he was chairman of the board of ARCA biopharma and Dendreon Corporation, and was executive chairman of Nile Therapeutics. "Richard...

advanced prostate Cancer. The study began in June 2010 and is supported by Dendreon. A Phase 1/2., Open label, dose escalation, selected dose comparison trail...

for commercial and clinical vaccine production for the European markets. Dendreon Cancer vaccine "Avax fact sheet Phase II data" (PDF). Archived from the...

(APC8015, Provenge) in patients with hormone refractory disease. Sponsor: Dendreon Corp. A Randomized, Multicenter, Single Blind Study in Men with Metastatic...

Strober (1961), immunologist at Stanford Medical School, co-founder of Dendreon Charles Cantor (1962), molecular geneticist; chief science officer at Sequenom...

producer William Haseltine, B.A. 1966 – founder of Cambridge BioSciences and Dendreon Corp. F. Warren Hellman, B.A. 1955 – founder of Hellman & Friedman and...

(2007-08-20). "Movers: Capital One, Thornburg Mortgage, Countrywide, Lowe's, Dendreon". Businessweek.com. Archived from the original on May 23, 2011. Retrieved...

University School of Medicine and co-founder of the biotechnology company Dendreon known for his work on eliminating the need for life long immune suppressive...

Investments center it is now the headquarters of Russell Investments; Dendreon and others also have offices there. When SAM moved downtown, they left...